Treat-to-Target (T2T) Strategy: The APP’s Role in IBD
IBD physician assistant professional development resources supporting clinical skills, career growth and advanced practice in inflammatory b
Treat-to-Target (T2T) strategy: the APP’s role in IBD promotes the achievement of sustained remission, avoidance of complications, and enhancement of long-term prognosis in patients suffering from inflammatory bowel disease.
The goal of T2T strategies is broader than the alleviation of symptoms. T2T incorporates the use of clearly defined clinical, biochemical, and endoscopic goals that direct the clinician’s therapeutic modifications. The role of APPs is vital in the achievement of outcome-driven care, monitoring of defined targets, and enhancement of sustained control of disease over time in patients with Crohn’s disease and ulcerative colitis. The resources provided by the IBD Community Network (IBDCN) enable APPs to use the T2T approach in the management of patients with IBD.
T2T (Treat-to-target) strategy: the APP (Advanced Practice Provider) role in IBD (Inflammatory Bowel Disease) is one of the main components to reach sustained remission, reduce the risk of complications, and improve the overall control of the disease over time. Advanced practice providers emphasize and improve the care given to IBD (Inflammatory Bowel Disease) patients.
The IBD (Inflammatory Bowel Disease) Community Network has tools, educational resources, and professional relations that APPs (Advanced Practice Providers) can use to confidently adopt T2T (Treat-to-target) strategies for better results for patients with inflammatory bowel disease.












